Literature DB >> 11106838

Antihypertensive drugs as predictors of type 2 diabetes among subjects with impaired glucose tolerance.

U Rajala1, Q Qiao, M Laakso, S Keinänen-Kiukaanniemi.   

Abstract

AIMS: to examine the incidence rate of progression to Type 2 diabetes and baseline prognostic risk factors, focusing on hypertension and antihypertensive medication, in a cohort (n=207) with impaired glucose tolerance (IGT).
METHODS: after 2 and 4.6 (1. 9-6.4) years new cases of diabetes were diagnosed by the oral glucose tolerance test (OGTT). Hypertension (BP 160/95 or antihypertensive medication) was included in multiple regression analyses to assess the effect of risk factors on the development of diabetes.
RESULTS: diabetes developed in 32 subjects (19%), an incidence of 41/1000 (95% CI 28-57/1000) person-years. In univariate analyses, progression to diabetes was associated with a high (>9.0 mmol/l) 2-h OGTT value (P=0.008), a high fasting insulin (>12.0 mU/l) level (P=0.000), a high triglyceride (>/=1.3 mmol/l) level (P=0.028), a high BMI (>/=28.0 kg/m(2)) (P=0.013) and hypertension (P=0.003). The risk for the development of diabetes was not increased in hypertensive subjects without antihypertensive medication compared with normotensive subjects (OR 0.8, 95% CI 0.3-2. 6). However, it was increased in subjects with on medication, especially diuretics alone or in combination with other drugs. Hypertensive subjects on diuretics had higher levels of fasting insulin and triglycerides and higher BMIs at baseline than normotensive subjects. After adjustment for 2-h OGTT, fasting insulin, triglycerides and BMI, the OR for diabetes was 7.7 (95% CI 2.1-28.2) in hypertensive subjects using diuretics alone or in combination with other drugs and 2.6 (95% CI 1.0-6.7) in those using other drugs compared with normotensive subjects. The OR of diabetes corresponding to a one-unit increase in the 2-h OGTT concentration was 2.5 (95% CI 1.6-4.0) in the whole cohort.
CONCLUSIONS: the rate of progression from IGT to Type 2 diabetes in this population was similar to that seen in other studies among Caucasian populations. The use of antihypertensive medication, especially diuretics, and a high 2-h OGTT level were significant predictors of subsequent deterioration to diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106838     DOI: 10.1016/s0168-8227(00)00189-3

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

1.  Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark.

Authors:  S S Rasmussen; C Glümer; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

2.  Alteration in fasting glucose after prolonged treatment with a thiazide diuretic.

Authors:  Jason H Karnes; Yan Gong; Meghan J Arwood; John G Gums; Karen L Hall; Marian C Limacher; Julie A Johnson; Rhonda M Cooper-DeHoff
Journal:  Diabetes Res Clin Pract       Date:  2014-04-13       Impact factor: 5.602

3.  Diabetes, prediabetes and cancer mortality.

Authors:  X H Zhou; Q Qiao; B Zethelius; K Pyörälä; S Söderberg; A Pajak; C D A Stehouwer; R J Heine; P Jousilahti; G Ruotolo; P M Nilsson; G Calori; J Tuomilehto
Journal:  Diabetologia       Date:  2010-05-21       Impact factor: 10.122

Review 4.  Differential effects of antihypertensive drugs on new-onset diabetes?

Authors:  William J Elliott
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

5.  Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark.

Authors:  S S Rasmussen; C Glümer; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2007-12-05       Impact factor: 10.122

Review 6.  Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.

Authors:  Jason H Karnes; Rhonda M Cooper-DeHoff
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-06

7.  Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients.

Authors:  Yong Hoon Kim; Ae-Young Her; Seung-Woon Rha; Byoung Geol Choi; Se Yeon Choi; Jae Kyeong Byun; Dong Oh Kang; Won Young Jang; Woohyeun Kim; Ju Yeol Baek; Woong Gil Choi; Tae Soo Kang; Jihun Ahn; Sang-Ho Park; Sung Hun Park; Ji Yeon Hong; Ji Young Park; Min-Ho Lee; Cheol Ung Choi; Chang Gyu Park; Hong Seog Seo
Journal:  J Diabetes Metab Disord       Date:  2020-04-03

8.  Proximal correlates of metabolic phenotypes during 'at-risk' and 'case' stages of the metabolic disease continuum.

Authors:  M T Haren; G Misan; J F Grant; J D Buckley; P R C Howe; A W Taylor; J Newbury; R A McDermott
Journal:  Nutr Diabetes       Date:  2012-01-16       Impact factor: 5.097

9.  A retrospective longitudinal cohort study of antihypertensive drug use and new-onset diabetes in Taiwanese patients.

Authors:  Ching-Ya Huang; Tsochiang Ma; Liyun Tien; Yow-Wen Hsieh; Shwu-Yi Lee; Hung-Yi Chen; Gwo-Ping Jong
Journal:  Biomed Res Int       Date:  2012-12-23       Impact factor: 3.411

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.